Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Reinhardt

Showing results (111-120 of 223) with videos related to

Pageof 23
Sort By:
Blood|July 30, 2005
In vitro profiling of the sensitivity of pediatric leukemia cells to tipifarnib: identification of T-cell ALL and FAB M5 AML as the most sensitive subsetsBianca F Goemans, Christian M Zwaan, Amy Harlow, et al.
Pediatric Blood & Cancer|April 12, 2011
CNS irradiation in pediatric acute myleoid leukemia: equal results by 12 or 18 Gy in studies AML-BFM98 and 2004Ursula Creutzig, Martin Zimmermann, Jean-Pierre Bourquin, et al.
Scientific Reports|February 3, 2018
Panton-Valentine Leukocidin associated with S. aureus osteomyelitis activates platelets via neutrophil secretion productsSilke Niemann, Anne Bertling, Martin F Brodde, et al.
Genes, Chromosomes & Cancer|March 29, 2012
Next-generation sequencing for minimal residual disease monitoring in acute myeloid leukemia patients with FLT3-ITD or NPM1 mutationsFelicitas Thol, Britta Kölking, Frederik Damm, et al.
Blood|August 17, 2006
Clinical implications of FLT3 mutations in pediatric AMLSoheil Meshinchi, Todd A Alonzo, Derek L Stirewalt, et al.
Archives of Disease in Childhood|July 2, 2011
Long term survival in children with acute leukaemia and complications requiring mechanical ventilationDaniel Steinbach, Bernhard Wilhelm, Hans-Rudolf Kiermaier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 5, 2010
Prognostic impact of specific chromosomal aberrations in a large group of pediatric patients with acute myeloid leukemia treated uniformly according to trial AML-BFM 98Christine von Neuhoff, Dirk Reinhardt, Annette Sander, et al.
Blood|January 25, 2003
Gemtuzumab ozogamicin: first clinical experiences in children with relapsed/refractory acute myeloid leukemia treated on compassionate-use basisChristian M Zwaan, Dirk Reinhardt, Selim Corbacioglu, et al.
Blood|July 1, 2011
Analysis of GATA1 mutations in Down syndrome transient myeloproliferative disorder and myeloid leukemiaKate A Alford, Katarina Reinhardt, Catherine Garnett, et al.
Cancers|July 14, 2023
Understanding <i>WT1</i> Alterations and Expression Profiles in Hematological MalignanciesNaghmeh Niktoreh, Lisa Weber, Christiane Walter, et al.
Pageof 23

Showing results (111-120 of 223) with videos related to

Sort By:
Pageof 23
Blood|July 30, 2005
In vitro profiling of the sensitivity of pediatric leukemia cells to tipifarnib: identification of T-cell ALL and FAB M5 AML as the most sensitive subsetsBianca F Goemans, Christian M Zwaan, Amy Harlow, et al.
Pediatric Blood & Cancer|April 12, 2011
CNS irradiation in pediatric acute myleoid leukemia: equal results by 12 or 18 Gy in studies AML-BFM98 and 2004Ursula Creutzig, Martin Zimmermann, Jean-Pierre Bourquin, et al.
Scientific Reports|February 3, 2018
Panton-Valentine Leukocidin associated with S. aureus osteomyelitis activates platelets via neutrophil secretion productsSilke Niemann, Anne Bertling, Martin F Brodde, et al.
Genes, Chromosomes & Cancer|March 29, 2012
Next-generation sequencing for minimal residual disease monitoring in acute myeloid leukemia patients with FLT3-ITD or NPM1 mutationsFelicitas Thol, Britta Kölking, Frederik Damm, et al.
Blood|August 17, 2006
Clinical implications of FLT3 mutations in pediatric AMLSoheil Meshinchi, Todd A Alonzo, Derek L Stirewalt, et al.
Archives of Disease in Childhood|July 2, 2011
Long term survival in children with acute leukaemia and complications requiring mechanical ventilationDaniel Steinbach, Bernhard Wilhelm, Hans-Rudolf Kiermaier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 5, 2010
Prognostic impact of specific chromosomal aberrations in a large group of pediatric patients with acute myeloid leukemia treated uniformly according to trial AML-BFM 98Christine von Neuhoff, Dirk Reinhardt, Annette Sander, et al.
Blood|January 25, 2003
Gemtuzumab ozogamicin: first clinical experiences in children with relapsed/refractory acute myeloid leukemia treated on compassionate-use basisChristian M Zwaan, Dirk Reinhardt, Selim Corbacioglu, et al.
Blood|July 1, 2011
Analysis of GATA1 mutations in Down syndrome transient myeloproliferative disorder and myeloid leukemiaKate A Alford, Katarina Reinhardt, Catherine Garnett, et al.
Cancers|July 14, 2023
Understanding <i>WT1</i> Alterations and Expression Profiles in Hematological MalignanciesNaghmeh Niktoreh, Lisa Weber, Christiane Walter, et al.
Pageof 23